Preformed Line Products
- Market cap
- 1.98B
- P/E (TTM)i
- 45.62
- P/Bi
- 4.00
- EPSi
- 7.14
- Div yieldi
- 0.21%
- 52W posi
- 69%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 2 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.1 percentage points.
Institutional ownership
- Held by institutions
- 70.38% +0.14pp
- Institutions
- 244 +2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-09-08
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 20 buys · 30 sells
| Name | Role | Stake |
|---|---|---|
| Randall Ruhlman | Former Director | 23.37% |
| Robert Ruhlman | Chairperson & CEO | 22.19% |
| Maegan Ruhlman Cross | Director | 0.50% |
| Jon Ruhlman | President | 0.44% |
| Andrew Klaus | Chief Financial Officer | 0.28% |
| John Olenik | -- | 0.13% |
| R. Kestner | Independent Director | 0.13% |
| Glenn Corlett | Independent Director | 0.11% |
| Richard Gascoigne | Independent Director | 0.08% |
| Timothy O’Shaughnessy | Officer | 0.07% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-07 | Randall Ruhlman | Former Director | Open Market Disposition | -5,142 | $400.04–407.78 |
| 2026-08-18 | Randall Ruhlman | Former Director | Intent to Sell (Form 144) | -10,000 | $444.76 |
| 2026-08-04 | Glenn Corlett | Independent Director | Open Market Disposition | -2,000 | $457.02 |
| 2026-08-02 | Randall Ruhlman | Former Director | Other Acquisition | +9,121 | $358.15 |
| 2026-08-02 | Randall Ruhlman | Former Director | Other Disposition | -9,121 | $358.15 |
| 2026-06-11 | Andrew Klaus | Chief Financial Officer | Sale to Issuer | -635 | $362.22 |
| 2026-06-10 | Jon Ruhlman | President | Sale to Issuer | -1,000 | $360.68 |
| 2026-06-09 | Timothy O’Shaughnessy | Officer | Sale to Issuer | -750 | $360.91 |
| 2026-06-09 | John Olenik | -- | Sale to Issuer | -1,000 | $360.91 |
| 2026-06-09 | Assaad Morcos | -- | Derivative Exercise and Sale | -1,000 | $132.40–360.91 |
| 2026-06-08 | Robert Ruhlman | Chairperson & CEO | Other Disposition | -36,000 | -- |
| 2026-06-08 | Jon Ruhlman | President | Other Acquisition | +18,000 | -- |
| 2026-06-08 | Maegan Ruhlman Cross | Director | Other Acquisition | +18,000 | -- |
| 2026-06-07 | John Hofstetter | Executive Vice President of US Operations | Sale to Issuer | -3,446 | $358.45 |
| 2026-03-12 | Robert Ruhlman | Chairperson & CEO | Sale to Issuer | -2,500 | $259.73 |
| 2026-03-11 | Glenn Corlett | Independent Director | Sale to Issuer | -400 | $260.24 |
| 2026-03-11 | John Olenik | -- | Sale to Issuer | -752 | $260.84 |
| 2026-03-09 | Dennis McKenna | Chief Operating Officer | Sale to Issuer | -7,887 | $260.34 |
| 2026-03-09 | Caroline Saylor | Former General Counsel | Sale to Issuer | -1,547 | $260.34 |
| 2026-03-09 | David Sunkle | Director | Sale to Issuer | -1,600 | $260.34 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 06:43:52 · For reference only, not investment advice and not tailored to your situation.